Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-086X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results ; day:6 ; month:3 ; year:2019 ; pages:1-10
CardioVascular and interventional radiology ; (6.3.2019), 1-10

Urheber
Lucatelli, Pierleone
Ginnani Corradini, Luca
Rubeis, Gianluca De
Rocco, Bianca
Basilico, Fabrizio
Cannavale, Alessandro
Nardis, Pier Giorgio
Corona, Mario
Saba, Luca
Catalano, Carlo
Bezzi, Mario
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00270-019-02192-y
URN
urn:nbn:de:101:1-2019040103025379303746
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:03 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lucatelli, Pierleone
  • Ginnani Corradini, Luca
  • Rubeis, Gianluca De
  • Rocco, Bianca
  • Basilico, Fabrizio
  • Cannavale, Alessandro
  • Nardis, Pier Giorgio
  • Corona, Mario
  • Saba, Luca
  • Catalano, Carlo
  • Bezzi, Mario
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients

Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) plus apatinib versus DEB-TACE alone in treating huge hepatocellular carcinoma patients

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS

Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose

Hochschulschrift

Konventionelle versus Drug-Eluting Beads transarterielle Chemoembolisation (cTACE vs. DEB-TACE) beim hepatozellulärem Karzinom mit Pfortaderthrombose

Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis

Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial

Verbundene Objekte